Table 3.
Yingliu Treatment (40) | Control Treatment (40) | ||
---|---|---|---|
FT3 (pmol/l) | pre-treatment | 18.22 (14.87) | 14.25 (14.88) |
6 weeks after treatment | 8.92 (8.53)* | 5.60 (6.42)* | |
Difference after 6 weeks of treatment | 9.3 (6.35) | 8.65 (8.46) | |
12 weeks after treatment | 5.44 (3.52)* | 5.61 (5.19)* | |
Difference after 12 weeks of treatment | 12.78 (11.35)▲ | 8.64 (9.69) | |
FT4 (pmol/l) | pre-treatment | 46.75 (34.95) | 39.34 (27.24) |
6 weeks after treatment | 25.76 (20.10)* | 19.30 (14.00)* | |
Difference after 6 weeks of treatment | 20.99 (14.85) | 20.04 (13.24) | |
12 weeks after treatment | 15.85 (11.64)* | 16.93 (10.50)* | |
Difference after 12 weeks of treatment | 30.90 (23.31)▲ | 22.41 (16.74) | |
TSH (mIU/L) | pre-treatment | 0.004 (0.00) | 0.004 (0.00) |
6 weeks after treatment | 0.004 (0.003)* | 0.004 (0.080)* | |
Difference after 6 weeks of treatment | 0.00 (0.003) | 0.00 (0.080) | |
12 weeks after treatment | 0.010 (2.26)* | 0.005 (0.59)* | |
Difference after 12 weeks of treatment | -0.006 (2.26) | -0.001 (0.59) | |
TGAb (IU/ML) | pre-treatment | 89.90 (370.92) | 89.62 (355.11) |
6 weeks after treatment | 77.35 (335.90)* | 83.00 (338.20)* | |
Difference after 6 weeks of treatment | 12.55 (35.02) | 6.62 (16.91) | |
12 weeks after treatment | 65.75 (295.71)* | 71.35 (334.23)* | |
Difference after 12 weeks of treatment | 24.15 (75.21)▲ | 18.27 (20.88) | |
TPOAb (IU/ML) | pre-treatment | 54.80 (229.20) | 27.80 (250.15) |
6 weeks after treatment | 58.50 (193.30)* | 24.40 (225.60)* | |
Difference after 6 weeks of treatment | -3.70 (35.9) | 3.40 (24.55) | |
12 weeks after treatment | 40.40 (168.83)* | 24.60 (202.58)* | |
Difference after 12 weeks of treatment | 14.40 (60.37) | 3.20 (47.57) | |
TRAb (mIU/ML) | pre-treatment | 12.89 (17.10) | 12.17 (27.43) |
6 weeks after treatment | 8.46 (12.55)* | 12.68 (24.91)** | |
Difference after 6 weeks of treatment | 4.43 (4.55) | 0.51 (2.52) | |
12 weeks after treatment | 6.17 (9.11)* | 9.04 (19.57)* | |
Difference after 12 weeks of treatment | 6.72 (7.99)▲ | 3.13 (7.86) |
Compared with pre-treatment,
P < 0.01;
P < 0.05;
compared with control group,
P < 0.05.